There are currently> 51 million people with epilepsy (PWE) in the world and every year> 4.9
million people develop new-onset epilepsy. The cornerstone of treatment in PWE is drug …

No disease-modifying or preventive treatments exist for epilepsy, and their development
remains a major unmet need.. We have entered though the era of change in the treatment of …

The worsening of neurological status that occurs early after acute ischemic stroke (AIS)
remains a serious issue, and the inflammatory response plays a key role in stroke …

Despite progress in the development of anti‐seizure medications (ASMs), one third of
people with epilepsy have drug‐resistant epilepsy (DRE). The working definition of DRE …

Objective There is a lack of studies using the International League Against Epilepsy (ILAE)
recommendation to define drug-resistant epilepsy (DRE). This study evaluated the seizure …

There is currently no evidence to support the use of antiseizure medications to prevent
unprovoked seizures following stroke. Experimental animal models suggested a potential …

Background Endovascular treatment (EVT) is the standard of care of ischaemic stroke due to
occlusion of large vessels. Although EVT can significantly improve short-and long-term …

Background: The study aimed to develop a model and build a nomogram to predict the
probability of drug resistance in people with post-stroke epilepsy (PSE). Methods: Subjects …

In 2019, over 130 people from several countries travelled to Gothenburg, Sweden, for the
Seizures and Stroke Congress, the first international conference devoted to post-stroke …

Abstract Purpose of Review Stroke is the most common cause of seizures and epilepsy in
older adults. This educational paper aims to give an update on current clinical aspects of …